Every pouch debate eventually becomes this one, because these are the flagship brands of the category's two big market shapes: ZYN on the American shelf, VELO on the European one. The comparisons written elsewhere tend to end with a crowned winner and a buy button. This one ends with the facts that actually differ, laid side by side, because on labelled facts the honest answer is that each brand is built for a different market's rules.
This post is part of the brands cluster. The full field, compared on the same terms, is in nicotine pouch brands compared.
One ground rule first. Pouches are adult products. Snus Watch is written for adult nicotine users: 18 and over in Europe and the UK, 21 and over in the US.
Who makes each brand?
ZYN was created by Swedish Match, the Swedish snus house, and is now owned by Philip Morris International, which bought Swedish Match and runs ZYN through it as a wholly owned subsidiary. The brand's centre of gravity is the United States: the FDA's marketing orders of January 2025 authorized twenty ZYN products, and in June 2026 the FDA issued modified risk granted orders for those same products. Both orders are recorded here as market facts, the kind of regulatory milestones that shape a shelf; neither is a verdict on the product, and this site does not treat them as one.
VELO is BAT's pouch brand, born in Sweden and produced in Europe, in VELO's own words, and built from the start as a global brand rather than a national one. Where ZYN's story is one home market served deeply, VELO's is many markets served at once, with the range redrawn at each border.
The ownership picture behind both brands, and the rest of the shelf, is mapped in who owns the nicotine pouch brands.
The two ranges, side by side
| Fact | ZYN | VELO |
|---|---|---|
| Owner | Philip Morris International (Swedish Match) | BAT |
| Lead market | United States | Europe and the UK |
| US line | 10 flavours at 3 and 6 mg (FDA-authorized); ZYN Ultra at 9 and 11 mg | VELO Plus at 3, 6 and 9 mg |
| European line | Market-specific lineups; the range is not published as one span | Dot ladder one to six; UK official list currently 4, 6, 10 and 11 mg, wider range to 17 mg in other markets |
| Strength labelling | Printed mg figure leads | Dots lead, printed mg figure alongside |
| Formats | Slim, semi-dry (Ultra: slim, moist) | Mini and slim |
| Pouches per can | 15 (20 in Ultra) | 15 mini, 20 slim |
| Nicotine source (US lines) | Plant-derived | VELO Plus: synthetic |
Figures are published label data checked in October 2026, from the sources below. Ranges change and markets differ; the table records how each brand is built, not a stock list.
Why does US ZYN stop at 6 mg when European VELO reaches 17?
Because the two shelves are fenced differently. The US is a list market: a pouch can be sold only if the FDA has authorized that specific product. Swedish Match applied for, and received, orders covering the 3 and 6 mg line, so that is the shelf. When the company wanted higher strengths in the US, it built a separate line, ZYN Ultra, rather than stretching the original.
Europe has no single authorization list. Each country sets its own frame, from Denmark's 9 mg cap to markets with no cap at all, and VELO's dot ladder stretches or compresses to fit. The 17 mg top end exists where the local frame allows it; the UK's official VELO list currently stops at 11 mg. The ladder is one system, the rungs available are local.
This is also why the strength guide insists on converting everything to mg per pouch before comparing: a 4-dot VELO and a US ZYN can are answers to different regulatory questions, and only the printed mg figure translates between them.
Dots versus numbers: does the labelling actually matter?
On the shelf, yes, in one specific way. ZYN's printed figure tells you the strength before you pick the can up. VELO's dots tell you where a can sits inside VELO's own range, and the mg figure, printed smaller, tells you the strength. A 3-dot VELO is roughly 8 to 10 mg per pouch depending on the market; there is no ZYN can where you have to know that kind of conversion to read the front.
Neither system is a trick. Dots are a ladder for a range that spans 4 to 17 mg across dozens of markets; plain numbers suit a range that, in its lead market, spans two strengths. The labelling follows the shape of the range, which follows the shape of the regulation. The conversion piece covers the third dialect, mg per gram, for cans that lead with concentration instead.
So which facts should decide it for a buyer?
The local ones. In the US, the real comparison is ZYN's authorized 3 and 6 mg line (or Ultra at 9 and 11) against VELO Plus at 3, 6 and 9, can counts of 15 against 20, semi-dry against moist formats. In Europe, it is VELO's ladder against the wider ZYN range sold there, under whatever cap your country sets. Any comparison that does not name its market first is comparing two brands that never meet on the same shelf.
And on the facts themselves, neither brand's table row contains a verdict. That is deliberate, here and across the brands hub.
FAQ
Is VELO stronger than ZYN?
In Europe, VELO's published top end (17 mg per pouch) sits above the strengths ZYN typically shelves there, and in the US the authorized ZYN line stops at 6 mg while VELO Plus reaches 9. But brand-level strength is a property of ranges, not pouches: compare the two cans in front of you in mg per pouch, because the overlap between the ranges is wide.
Why does ZYN come in cans of 15?
The US ZYN line is packed at 15 pouches per can (ZYN Ultra moved to 20). VELO packs 15 in mini and 20 in slim. The count matters for price comparisons: divide the can price by the count before comparing across brands.
Are ZYN and VELO made by the same company?
No. They are the pouch brands of two rival tobacco groups: Philip Morris International owns ZYN through Swedish Match, and BAT owns VELO. The full map is in who owns the nicotine pouch brands.
What is VELO Plus, and is it the same as European VELO?
VELO Plus is BAT's US line: slim moist pouches at 3, 6 and 9 mg, 20 per can, made with synthetic nicotine. It shares the brand and the owner with European VELO but not the product build, which is why this comparison treats it as its own row.
Which brand came first?
Both are Swedish creations of the 2010s pouch wave, ZYN from Swedish Match's snus tradition and VELO built by BAT as a global brand from a Swedish base. The more useful difference is not age but strategy: one market deep, versus many markets wide.
Sources
- Philip Morris International / Swedish Match, FDA authorization of 20 ZYN products at 3 mg and 6 mg (PR Newswire): https://www.prnewswire.com/in/news-releases/fda-authorizes-all-zyn-nicotine-pouch-products-currently-marketed-by-swedish-match-in-the-us-302361582.html
- U.S. Food and Drug Administration, Modified Risk Tobacco Products (Swedish Match USA, ZYN: Modified Risk Granted Order, 30 June 2026). Cited here as a regulatory authorization fact only; Snus Watch does not repeat the authorized claim wording and makes no safety claim of its own: https://www.fda.gov/tobacco-products/advertising-and-promotion/modified-risk-tobacco-products
- VELO UK, Frequently Asked Questions (born in Sweden, produced in Europe; current UK strengths 4, 6, 10 and 11 mg; 20 pouches per slim can, 15 per mini can): https://www.velo.com/en-gb/pages/frequently-asked-questions
- Northerner, ZYN vs ZYN Ultra (US ZYN: 15 pouches per can, semi-dry; Ultra: 20 per can, moist, 9 and 11 mg): https://www.northerner.com/us/the-northerner/review/zyn-vs-zyn-ultra
- Northerner, Nicotine Pouch Brands (VELO Plus US line: 3, 6 and 9 mg, 20 slim pouches per can, synthetic nicotine): https://www.northerner.com/us/nicotine-pouches/brands
- Northerner, VELO Strength Guide (the one-to-six dot ladder and its mg mapping): https://www.northerner.com/uk/velo/velo-strengths